Surgery in Early Metastatic Seminoma: A Phase II Trial of Retroperitoneal Lymph Node Dissection for Testicular Seminoma With Limited Retroperitoneal Lymphadenopathy.
Siamak DaneshmandClint CaryTimothy MastersonLawrence EinhornNabil AdraStephen A BoorjianChristian K KollmannsbergerAnne SchuckmanAlan SoPeter C BlackAditya BagrodiaEila SkinnerMehrdad AlemozaffarTimothy BrandScott E EggenerPhillip M PierorazioKelly L StrattonLucia NappiCraig R NicholsChunqiao LuoMing LiBrian HuPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
RPLND is a treatment option for testicular seminoma with clinically low-volume retroperitoneal lymphadenopathy and is associated with low long-term morbidity.
Keyphrases
- germ cell
- robot assisted
- minimally invasive
- small cell lung cancer
- coronary artery bypass
- lymph node
- rectal cancer
- prostate cancer
- clinical trial
- sentinel lymph node
- coronary artery disease
- acute coronary syndrome
- radiation therapy
- combination therapy
- atrial fibrillation
- percutaneous coronary intervention
- replacement therapy
- locally advanced
- placebo controlled